|
Abstract
USC scientists have developed novel N-(chroman-3-yl) benzamide compounds, which have shown potent antimicrobial activity against antibiotic-resistant Staphylococcus aureus (SA) and enhanced immune cell killing. In vitro tests revealed a four-fold reduction in the concentration needed to inhibit the growth of the bacterium. When these compounds...
|